Cited by 54Nerve injury and regenerationGlaucoma and retinal disordersMicroRNA in disease regulation

Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush

Li, Hong-Jiang, Pan, Yuan-Bo, Sun, Zhao-Liang, Sun, Yi-Yu, Yang, Xi-Tao, Feng, Dong-Fu·2018·Neuropharmacology

Abstract

Optic nerve injury is a leading cause of irreversible visual impairment worldwide and can even cause blindness. Excessive activation of astrocytes has negative effects on the repair and recovery of retinal ganglion cells following optic nerve injury. However, the molecular and cellular mechanisms underlying astrocyte activation after optic nerve injury remain largely unknown. In the present study, we explored the effects of microRNA-21 (miR-21) on axon regeneration and flash visual evoked potential (F-VEP) and the underlying mechanisms of these effects based on astrocyte activation in the rat model of optic nerve crush (ONC). To the best of our knowledge, this article is the first to report that inhibition of miR-21 enhances axonal regeneration and promotes functional recovery in F-VEP in the rat model of ONC. Furthermore, inhibition of miR-21 attenuates excessive astrocyte activation and glial scar formation, thereby promoting axonal regeneration by regulating the epidermal growth factor receptor (EGFR) pathway. In addition, we observed that the expression of tissue inhibitor of metalloproteinase-3, a target gene of miR-21, was inhibited during this process. Taken together, these findings demonstrate that inhibition of miR-21 regulates the EGFR pathway, ameliorating excessive astrocyte activation and glial scar progression and promoting axonal regeneration and alleviating impairment in F-VEP function in a model of ONC. This study's results suggest that miR-21 may represent a…

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2018.04.028

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, H.-J., Pan, Y.-B., Sun, Z.-L., Sun, Y.-Y., Yang, X.-T., & Feng, D.-F.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
Feng, Dong-Fu
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2018-07
Volume
137
Pages
33-49
ISSN
0028-3908 (ISSN-L)
OpenAlex
W2802122992
Cited by
54
References
2
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 11 · 2021: 10 · 2020: 2 · 2019: 5
FWCI
1.94
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81772059, 81401587)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
miR-21, optic nerve crush, astrocyte activation, axon regeneration, glial scar, epidermal growth factor receptor, TIMP-3, flash visual evoked potentials, optic nerve injury, microRNA inhibition
MeSH terms
Animals, Astrocytes, Axons, Cells, Cultured, Cicatrix, Disease Models, Animal, Evoked Potentials, Visual, Male, Nerve Regeneration, Optic Nerve, Random Allocation, Rats, Sprague-Dawley, Neuroprotective Agents, Optic Nerve Injuries, MicroRNAs, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review